Exchange: NASDAQ·Updated 08:13 AM EDT
INDP logo

INDP Indaptus Therapeutics Inc

$1.14
$0.00
(0.00%)
Pre-Market
Prev Close $1.14
Mkt Cap$151.9M
Vol1,299.00

About INDP

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
38

Bearish Sentiment

How do you feel about INDP?

Advertisement|Remove ads.